HSBC Global Investment Research released a report on CHINA LIFE (02628.HK) -0.200 (-0.794%) Short selling $173.00M; Ratio 74.075% , which charted a 44% YoY growth in net profit in 2025, implying a net loss of RMB13.7 billion in 4Q25, reflecting earnings volatility amid market corrections. The NBV grew by 36% YoY in 2025, above the broker's and market's expectations by 11% and 8%, respectively, on better-than-expected NBV margin. The annual DPS was RMB0.856, 3% below market expectations. Related News CICC Notes Significant Improvement in China Life (02628.HK) New Business Liability Guarantee Costs, Maintains 'Outperform' RatingThe H-share target price was reduced from HKD28 to HKD26, and the A-share target price of China Life (601628.SH) -0.660 (-1.783%) was lowered from RMB49 to RMB46. A Hold rating for both H-shares and A-shares was maintained.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.) (A Shares quote is delayed for at least 15 mins.)
AASTOCKS Financial News